Home > Worldwide > Takeda Pharmaceuticals North America, Inc.
Main contents starts here
Takeda Pharmaceuticals North America, Inc.
| Home page | |
|---|---|
| Business | Marketing |
| Key Products | (pioglitazone hydrochloride) |
| (pioglitazone HCl and metformin HCl) | |
| (pioglitazone HCl and glimepiride) | |
| (lubiprostone)* | |
| (ramelteon) | |
| (lansoprazole) | |
| (dexlansoprazole) | |
| (febuxostat) | |
| *Amitiza is a trademark of Sucampo Pharmaceuticals, Inc. | |
| Address | One Takeda Parkway, Deerfield, IL 60015, USA |
| Telephone | +1-224-554-6500 |
| Contact | |
| Founded | 1998 |
Takeda Pharmaceuticals North America, Inc. (TPNA) is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
In the United States, TPNA currently markets oral diabetes, sleep, gastroenterology, cholesterol lowering treatments and chronic management of hyperuricemia in patients with gout, and through the Takeda Global Research & Development Center, Inc. the company has a robust pipeline with compounds in development for diabetes, cardiovascular disease and other conditions.
[*]The information presented at each company's website is governed by laws and regulations of that particular country, and therefore is intended for residents in that country only.
Photo
